Translational Development Acquisition Corp. launches separate trading of class A shares and warrants on Nasdaq
Translational Development Acquisition Corp. has initiated the separate trading of its Class A ordinary shares and warrants on The Nasdaq Global Market, marking a key ... Read More
Translational Development Acquisition Corp. secures $172.5m in IPO with full over-allotment exercise
NEW Translational Development Acquisition Corp. has successfully closed its initial public offering (IPO), generating $172.5 million in gross proceeds. The offering included the issuance of ... Read More